Stockreport

Clover Health Reports Strong First Quarter 2024 Financial Results; Improves Guidance to Target Full-Year 2024 Adjusted EBITDA Profitability [Yahoo! Finance]

Clover Health Investments, Corp. - Class A Common stock  (CLOV) 
PDF First Quarter Adjusted EBITDA profitability of $6.8 million versus prior period loss of $37.5 million Improves 2024 guidance to Insurance Revenue of $1.30 billion - $ [Read more]